Underrepresentation of non-white children in trials of statins in children with heterozygous familial hypercholesterolemia

Medicine & Life Sciences

• Hyperlipoproteinemia Type II 100%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 78%
• Child 35%
• Founder Effect 28%
• Pediatrics 21%
• European Continental Ancestry Group 12%
• Healthy People Programs 9%
• Healthcare Disparities 9%
• Medical History Taking 9%
• Clinical Trials 8%
• Population 7%
• Pharmacogenetics 7%
• Vulnerable Populations 7%
• Hypercholesterolemia 6%
• Cardiology 6%
• Cholesterol 4%
• Public Health 4%
• Lipids 4%
• Guidelines 4%
• Education 4%
• Health 3%